Vertex Pharmaceuticals (VRTX) Capital Expenditures (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.71% |
| Dec 31, 2025 | 46.76% |
| Sep 30, 2025 | -30.13% |
| Jun 30, 2025 | 257.99% |
| Mar 31, 2025 | -56.05% |
| Dec 31, 2024 | 36.78% |
| Sep 30, 2024 | -1.88% |
| Jun 30, 2024 | 0.88% |
| Mar 31, 2024 | 17.73% |
| Dec 31, 2023 | 43.10% |
| Sep 30, 2023 | -31.88% |
| Jun 30, 2023 | 41.57% |
| Mar 31, 2023 | 25.30% |
| Dec 31, 2022 | -38.01% |
| Sep 30, 2022 | 1.69% |
| Jun 30, 2022 | -16.19% |
| Mar 31, 2022 | 2.91% |
| Dec 31, 2021 | 17.94% |
| Sep 30, 2021 | 5.01% |
| Jun 30, 2021 | -29.62% |
| Mar 31, 2021 | 48.67% |
| Dec 31, 2020 | -72.72% |
| Sep 30, 2020 | 878.48% |
| Jun 30, 2020 | -8.15% |
| Mar 31, 2020 | 16.40% |
| Dec 31, 2019 | -31.21% |
| Sep 30, 2019 | 48.50% |
| Jun 30, 2019 | -9.33% |
| Mar 31, 2019 | 15.31% |
| Dec 31, 2018 | -25.18% |
| Sep 30, 2018 | -29.38% |
| Jun 30, 2018 | 1.14% |
| Mar 31, 2018 | -31.88% |
| Dec 31, 2017 | 53.73% |
| Sep 30, 2017 | 60.89% |
| Jun 30, 2017 | 56.57% |
| Mar 31, 2017 | -24.95% |
| Dec 31, 2016 | 6.52% |
| Sep 30, 2016 | -12.78% |
| Jun 30, 2016 | 32.94% |
| Mar 31, 2016 | -4.41% |
| Dec 31, 2015 | 42.40% |
| Sep 30, 2015 | -34.45% |
| Jun 30, 2015 | 27.11% |
| Mar 31, 2015 | -28.06% |
| Dec 31, 2014 | 57.84% |
| Sep 30, 2014 | -20.54% |
| Jun 30, 2014 | -24.64% |
| Mar 31, 2014 | 7.29% |
| Dec 31, 2013 | -21.84% |
| Sep 30, 2013 | 927.98% |
| Jun 30, 2013 | -89.16% |
| Mar 31, 2013 | -40.79% |
| Dec 31, 2012 | 31.08% |
| Sep 30, 2012 | 37.66% |
| Jun 30, 2012 | 152.53% |
| Mar 31, 2012 | -34.02% |
| Dec 31, 2011 | -6.57% |
| Mar 31, 2011 | -66.38% |
| Dec 31, 2010 | 33.22% |
| Sep 30, 2010 | 11.81% |
| Jun 30, 2010 | 211.45% |
| Mar 31, 2010 | -58.96% |
| Dec 31, 2009 | 59.44% |
| Sep 30, 2009 | 3.64% |
| Jun 30, 2009 | -30.29% |